JP2019515672A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019515672A5 JP2019515672A5 JP2018554677A JP2018554677A JP2019515672A5 JP 2019515672 A5 JP2019515672 A5 JP 2019515672A5 JP 2018554677 A JP2018554677 A JP 2018554677A JP 2018554677 A JP2018554677 A JP 2018554677A JP 2019515672 A5 JP2019515672 A5 JP 2019515672A5
- Authority
- JP
- Japan
- Prior art keywords
- host cell
- amino acid
- acid sequence
- seq
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022139098A JP2022164858A (ja) | 2016-04-20 | 2022-09-01 | 免疫調整性ｉｌ２ｒ融合タンパク質およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662325428P | 2016-04-20 | 2016-04-20 | |
| US62/325,428 | 2016-04-20 | ||
| PCT/US2017/028693 WO2017184901A1 (en) | 2016-04-20 | 2017-04-20 | Immunomodulatory il2r fusion proteins and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022139098A Division JP2022164858A (ja) | 2016-04-20 | 2022-09-01 | 免疫調整性ｉｌ２ｒ融合タンパク質およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019515672A JP2019515672A (ja) | 2019-06-13 |
| JP2019515672A5 true JP2019515672A5 (https=) | 2020-05-28 |
| JP7198670B2 JP7198670B2 (ja) | 2023-01-04 |
Family
ID=58710057
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018554677A Active JP7198670B2 (ja) | 2016-04-20 | 2017-04-20 | 免疫調整性ｉｌ２ｒ融合タンパク質およびその使用 |
| JP2022139098A Ceased JP2022164858A (ja) | 2016-04-20 | 2022-09-01 | 免疫調整性ｉｌ２ｒ融合タンパク質およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022139098A Ceased JP2022164858A (ja) | 2016-04-20 | 2022-09-01 | 免疫調整性ｉｌ２ｒ融合タンパク質およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20190127435A1 (https=) |
| EP (1) | EP3445847B1 (https=) |
| JP (2) | JP7198670B2 (https=) |
| CN (1) | CN109312304A (https=) |
| CA (1) | CA3021455A1 (https=) |
| ES (1) | ES2981274T3 (https=) |
| WO (1) | WO2017184901A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4406604A3 (en) * | 2015-03-05 | 2024-10-23 | Fred Hutchinson Cancer Center | Immunomodulatory fusion proteins and uses thereof |
| JP7178906B2 (ja) * | 2016-05-19 | 2022-11-28 | ザ ジェネラル ホスピタル コーポレイション | ナチュラルキラー細胞および制御性Ｔ細胞の活性を強化するためのプラットフォームである、その受容体ＩＬ－２Ｒβに繋ぎ止められたインターロイキン－２ |
| CN119409836A (zh) * | 2017-03-17 | 2025-02-11 | 弗雷德哈钦森癌症中心 | 免疫调节融合蛋白及其用途 |
| CN109503715B (zh) * | 2017-09-15 | 2023-12-15 | 科济生物医药（上海）有限公司 | Il-4r的融合蛋白及其应用 |
| CN108504685A (zh) * | 2018-03-27 | 2018-09-07 | 宜明细胞生物科技有限公司 | 一种利用CRISPR/Cas9系统同源重组修复IL-2RG缺陷基因的方法 |
| CN110615843B (zh) * | 2018-06-20 | 2023-05-09 | 上海隆耀生物科技有限公司 | 一种包含第三信号受体的嵌合抗原受体及其应用 |
| CA3097443A1 (en) * | 2018-11-12 | 2020-05-22 | I-Mab Biopharma Us Limited | Fusion proteins containing cd47 antibodies and cytokines |
| EP3992204A4 (en) * | 2019-06-28 | 2023-09-27 | CRAGE medical Co., Limited | CELL FOR RESISTANCE TO TRANSPLANT REACTION AND METHOD |
| WO2021050752A1 (en) * | 2019-09-11 | 2021-03-18 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric orthogonal receptor proteins and methods of use |
| EP4031583A4 (en) * | 2019-09-16 | 2023-11-15 | Fred Hutchinson Cancer Center | CHIMERIC RECEPTOR PROTEINS AND THEIR USES |
| GB201913697D0 (en) * | 2019-09-23 | 2019-11-06 | King S College London | DAP10/DAP12 fusion polypeptides |
| EP4041893A4 (en) * | 2019-10-08 | 2023-08-30 | Provincial Health Services Authority | CHEMERACY CYTOKINE RECEPTORS |
| WO2021141986A1 (en) * | 2020-01-07 | 2021-07-15 | St. Jude Children's Research Hospital, Inc. | Chimeric gmcsf-il18 receptor |
| CN113249330A (zh) * | 2021-05-20 | 2021-08-13 | 深圳市先康达生命科学有限公司 | 免疫细胞及其应用 |
| JP2024542027A (ja) * | 2021-11-02 | 2024-11-13 | フレッド ハッチンソン キャンサー センター | 細胞標的療法を利用したがんの治療及び関連する研究プロトコル |
| IL322949A (en) | 2023-03-03 | 2025-10-01 | Arsenal Biosciences Inc | Systems targeting PSMA and CA9 |
| WO2025039159A1 (en) * | 2023-08-21 | 2025-02-27 | Hangzhou Hervor Therapeutics Co., Ltd | Synthetic cytokine signaling system, preparation method, and uses thereof |
| WO2025081123A1 (en) | 2023-10-12 | 2025-04-17 | Fred Hutchinson Cancer Center | Methods and compositions for improving t cell immunotherapy |
| WO2025085536A1 (en) * | 2023-10-16 | 2025-04-24 | Lankenau Institute For Medical Research | Biologic conjugates that inhibit production of inflammatory cells and methods of use |
| CN117511885B (zh) * | 2024-01-08 | 2024-06-11 | 青岛华赛伯曼医学细胞生物有限公司 | 提高识别和杀伤肿瘤能力的工程化til细胞及其应用 |
| WO2025245169A1 (en) | 2024-05-21 | 2025-11-27 | Fred Hutchinson Cancer Center | Immunotherapy cells equipped with a collagen-targeting payload |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| JPH08511000A (ja) * | 1993-04-06 | 1996-11-19 | フレッド ハッチンソン キャンサー リサーチ センター | リンパ球におけるキメラサイトカインレセプター |
| RU2420537C2 (ru) * | 2001-01-17 | 2011-06-10 | Трабьон Фармасьютикалз Инк. | Слитые белки связывающий домен-иммуноглобулин |
| US8119772B2 (en) | 2006-09-29 | 2012-02-21 | California Institute Of Technology | MART-1 T cell receptors |
| US9272002B2 (en) * | 2011-10-28 | 2016-03-01 | The Trustees Of The University Of Pennsylvania | Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting |
| CA2861491C (en) * | 2012-02-13 | 2020-08-25 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
| US10584158B2 (en) * | 2013-04-17 | 2020-03-10 | Baylor College Of Medicine | Immunosuppressive TGF-β signal converter |
-
2017
- 2017-04-20 WO PCT/US2017/028693 patent/WO2017184901A1/en not_active Ceased
- 2017-04-20 US US16/094,420 patent/US20190127435A1/en not_active Abandoned
- 2017-04-20 ES ES17724147T patent/ES2981274T3/es active Active
- 2017-04-20 CN CN201780037786.6A patent/CN109312304A/zh active Pending
- 2017-04-20 EP EP17724147.8A patent/EP3445847B1/en active Active
- 2017-04-20 CA CA3021455A patent/CA3021455A1/en active Pending
- 2017-04-20 JP JP2018554677A patent/JP7198670B2/ja active Active
-
2022
- 2022-09-01 JP JP2022139098A patent/JP2022164858A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019515672A5 (https=) | ||
| JP2020114264A5 (https=) | ||
| JP2022113880A5 (https=) | ||
| JP2020511136A5 (https=) | ||
| Weinkove et al. | Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations | |
| JP7198670B2 (ja) | 免疫調整性ｉｌ２ｒ融合タンパク質およびその使用 | |
| Salter et al. | Chimeric antigen receptor–modified T cells: CD19 and the road beyond | |
| AU2025205077A1 (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| JP2021177771A5 (https=) | ||
| US20240425565A1 (en) | Chimeric Natural Killer Cell Receptors and Method of Using Thereof | |
| Cao et al. | RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity | |
| KR102607152B1 (ko) | 키메라 항원 수용체 | |
| CN108884164B (zh) | 用于免疫疗法的经修饰细胞 | |
| JP2021519580A5 (https=) | ||
| FI4324851T3 (fi) | BCMA-spesifisiä kimeerisiä antigeenireseptoreita ja niiden käyttöjä | |
| JP2020513754A5 (https=) | ||
| US20210363245A1 (en) | Bicistronic chimeric antigen receptors targeting cd19 and cd20 and their uses | |
| JP2020517295A5 (https=) | ||
| JP2018064568A (ja) | Ｐｄ−ｌ１によって誘導される免疫寛容の低減 | |
| JP2020022456A5 (https=) | ||
| JP2022534680A5 (https=) | ||
| US20200354451A1 (en) | Chimeric antigen receptors comprising a human transferrin epitope sequence | |
| WO2017176525A1 (en) | Car having replicated binding motifs in a co-stimulatory domain | |
| JP2013515509A (ja) | ヘテロダイマー結合タンパク質およびその使用 | |
| IL255697B1 (en) | Preparations and methods for programming tcr using fusion proteins |